September 23, 2020
Article
More targeted therapies often have better toxicity profiles, allowing patients to remain adherent for longer.
September 22, 2020
Recent studies have analyzed how individuals with autoimmune conditions prescribed specialty medications may be affected by the COVID-19 pandemic.
September 21, 2020
Digital health tools were a major theme during the first-ever NASP Challenge, comprising 4 of the 5 finalists.
There were a number of FDA approvals in 2019 that were either the first new therapies or first in class approved for certain conditions, and the specialty pipeline is continuing to grow at a rapid pace.
Technology can help revolutionize how a pharmacy manages patients, collects payments, communicates, and can improve overall efficiency.
Clinical education, strong data analytics, and valuing collaboration are the best ways to provide patient support and access to specialty pharmaceutical manufacturers.
Protections for covered entities under the 340B program will most likely be affected by decisions in the Senate.
September 18, 2020
The COVID-19 pandemic has contributed to specialty pharmacy outpacing traditional pharmacy in non-discounted spending.
Data standardization has been an ongoing problem in the specialty pharmacy field, affecting both patients and providers when approaching treatments.
September 17, 2020
During the COVID-19 pandemic, many families and individuals have not been able to pay their out-of-pocket costs or do not have enough money saved to pay their deductibles.
